ICC Labs (TSXV:ICC) issued its interim financial results for its second quarter of 2018.

As quoted in the press release:

ICC Labs is also pleased to announce that has completed the construction of its 124,000 [square feet] greenhouse in Tabio, which is strategically located just north of Bogotá, where the Company intends to produce psychoactive cannabis with up to 20 [percent] of tetrahydrocannabinol (THC) for medicinal purposes, subject to approval of the TSX Venture Exchange.

“We are very enthusiastic about the development of our operations in Uruguay and Colombia. ICC Labs has been able to integrate its production of cannabidiol (CBD) oils in Uruguay using our proprietary CO2 extraction laboratory, which is located in Uruguay’s Free Trade Zone ‘Science Park’ and designed in compliance with the Good Manufacturing Practices (GMP) with the potential production capacity of THC derivatives in Colombia, which currently has the highest percentage (44 [percent]) of the global quota for cannabis assigned by the International Narcotics Control Board. ICC Labs has strengthened its position as one of the largest medicinal cannabis suppliers for the South America market,” commented Alejandro Antalich, CEO of ICC Labs.

During the second quarter of 2018, the Company focused its efforts on completing the construction of the new facilities in Uruguay and Colombia to take steps to expand both business segments.

Click here to read the full press release.

Source: globenewswire.com

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less

 Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.

For more information regarding the Company or the offering, please contact ir@hillstreetbevco.com, or

Keep reading... Show less